Skip to main content
Erschienen in: Calcified Tissue International 5/2017

02.02.2017 | Editorial

Fat and Bone: Where are We Now?

verfasst von: Paul Dimitri, Cliff Rosen

Erschienen in: Calcified Tissue International | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Excerpt

For decades there has been a debate about the impact of adiposity on the skeleton and we have by no means reached a conclusion. This exciting area has moved forward considerably, in part driven by a profound increase in the prevalence of obesity and osteoporosis. Initial clinical observations and studies with DXA suggested that obesity was osteoprotective, at least in adults [1, 2]. More recently it has been suggested that obese adults are more prone to fracture which may be confined to specific skeletal regions [3]. However, the increased risk of fracture in obese children implied that the impact of obesity on bone was age-dependent. This led to a number of studies examining the relationship between childhood obesity and bone with conflicting results, with some suggesting a positive relationship between adiposity and bone with others suggesting that excess fat is detrimental to the developing skeleton [2]. The issue of ‘obesity’ and the effect on the developing and adult skeleton was perhaps considered overly simplistic and subsequent work focusing on fat distribution demonstrated that, as with other metabolic conditions, it is visceral fat that appears to have a deleterious effect on the skeleton [4, 5] although again not all studies in adults are in agreement with this [3]. The advent of high resolution pQCT (HR-pQCT) has allowed us to examine the in-vivo relationship between fat and bone at a microstructural level in children with results demonstrating that the trabecular architecture is more likely altered in response to obesity [6], although from cross sectional studies in adults that may not be the case [7]. Thus, the debate relating to the impact of obesity on the skeleton lives on. In this Special Edition of ‘Fat and Bone’, Farr, Dimitri and Walsh address the past and current research relating to the impact of obesity on bone in children and adults. …
Literatur
2.
Zurück zum Zitat Dimitri P, Bishop N, Walsh JS, Eastell R (2012) Obesity is a risk factor for fracture in children but is protective against fracture in adults: a paradox. Bone 50:457–466CrossRefPubMed Dimitri P, Bishop N, Walsh JS, Eastell R (2012) Obesity is a risk factor for fracture in children but is protective against fracture in adults: a paradox. Bone 50:457–466CrossRefPubMed
3.
4.
Zurück zum Zitat Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD (2009) Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 94:3387–3393CrossRefPubMedPubMedCentral Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD (2009) Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 94:3387–3393CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Fu X, Ma X, Lu H et al (2011) Associations of fat mass and fat distribution with bone mineral density in pre- and postmenopausal Chinese women. Osteoporos Int 22(1):113–119CrossRefPubMed Fu X, Ma X, Lu H et al (2011) Associations of fat mass and fat distribution with bone mineral density in pre- and postmenopausal Chinese women. Osteoporos Int 22(1):113–119CrossRefPubMed
6.
Zurück zum Zitat Dimitri P, Jacques RM, Paggiosi M, King D, Walsh J, Taylor ZA, Frangi AF, Bishop N, Eastell R (2015) Leptin may play a role in bone microstructural alterations in obese children. J Clin Endocrinol Metab 100:594–602CrossRefPubMed Dimitri P, Jacques RM, Paggiosi M, King D, Walsh J, Taylor ZA, Frangi AF, Bishop N, Eastell R (2015) Leptin may play a role in bone microstructural alterations in obese children. J Clin Endocrinol Metab 100:594–602CrossRefPubMed
7.
Zurück zum Zitat Evans AL, Paggiosi MA, Eastell R, Walsh JS (2015) Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J Bone Miner Res 30(5):920–928CrossRefPubMed Evans AL, Paggiosi MA, Eastell R, Walsh JS (2015) Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J Bone Miner Res 30(5):920–928CrossRefPubMed
8.
Zurück zum Zitat Gordon CM, Bachrach LK, Carpenter TO et al (2008) Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD pediatric official positions. J Clin Densitom 11:43–58CrossRefPubMed Gordon CM, Bachrach LK, Carpenter TO et al (2008) Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD pediatric official positions. J Clin Densitom 11:43–58CrossRefPubMed
9.
Zurück zum Zitat Lewiecki EM et al (2016) Best practices for dual-energy X-ray absorptiometry measurement and reporting: international society for clinical densitometry guidance. J Clin Densitom 19(2):127–140CrossRefPubMed Lewiecki EM et al (2016) Best practices for dual-energy X-ray absorptiometry measurement and reporting: international society for clinical densitometry guidance. J Clin Densitom 19(2):127–140CrossRefPubMed
10.
11.
Zurück zum Zitat Svendsen OL, Hassager C, Skodt V, Christiansen C (1995) Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip, and forearm: a human cadaver study. J Bone Miner Res 10:868–873CrossRefPubMed Svendsen OL, Hassager C, Skodt V, Christiansen C (1995) Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip, and forearm: a human cadaver study. J Bone Miner Res 10:868–873CrossRefPubMed
12.
Zurück zum Zitat LaForgia J, Dollman J, Dale MJ, Withers RT, Hill AM (2009) Validation of DXA body composition estimates in obese men and women. Obesity 17:821–826CrossRefPubMed LaForgia J, Dollman J, Dale MJ, Withers RT, Hill AM (2009) Validation of DXA body composition estimates in obese men and women. Obesity 17:821–826CrossRefPubMed
13.
Zurück zum Zitat Ducy P et al (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100(2):197–207CrossRefPubMed Ducy P et al (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100(2):197–207CrossRefPubMed
14.
Zurück zum Zitat Takeda S et al (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111(3):305–317CrossRefPubMed Takeda S et al (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111(3):305–317CrossRefPubMed
15.
Zurück zum Zitat Bajayo A et al (2012) Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrual. Proc Natl Acad Sci USA 109(38):15455–15460CrossRefPubMedPubMedCentral Bajayo A et al (2012) Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrual. Proc Natl Acad Sci USA 109(38):15455–15460CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Offley SC et al (2005) Capsaicin-sensitive sensory neurons contribute to the maintenance trabecular bone integrity. J Bone Miner Res 20(2):257–267CrossRefPubMed Offley SC et al (2005) Capsaicin-sensitive sensory neurons contribute to the maintenance trabecular bone integrity. J Bone Miner Res 20(2):257–267CrossRefPubMed
17.
Zurück zum Zitat Vignaux G, Besnard S, Denise P, Elefteriou F (2015) The vestibular system: a newly identified regulator of bone homeostasis acting through the sympathetic nervous system. Curr Osteoporos Rep 13(4):198–205CrossRefPubMed Vignaux G, Besnard S, Denise P, Elefteriou F (2015) The vestibular system: a newly identified regulator of bone homeostasis acting through the sympathetic nervous system. Curr Osteoporos Rep 13(4):198–205CrossRefPubMed
18.
19.
Zurück zum Zitat Flank C, Fairfield H, Reagan M (2016) Signaling interplay between bone marrow adipose tissue and multiple myeloma cells. Front Endocrinol (Lausanne) 7:67 Flank C, Fairfield H, Reagan M (2016) Signaling interplay between bone marrow adipose tissue and multiple myeloma cells. Front Endocrinol (Lausanne) 7:67
Metadaten
Titel
Fat and Bone: Where are We Now?
verfasst von
Paul Dimitri
Cliff Rosen
Publikationsdatum
02.02.2017
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 5/2017
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-017-0240-0

Weitere Artikel der Ausgabe 5/2017

Calcified Tissue International 5/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.